gamma-carboline has been researched along with methylene blue in 1 studies
| Studies (gamma-carboline) | Trials (gamma-carboline) | Recent Studies (post-2010) (gamma-carboline) | Studies (methylene blue) | Trials (methylene blue) | Recent Studies (post-2010) (methylene blue) |
|---|---|---|---|---|---|
| 44 | 0 | 26 | 11,067 | 394 | 4,258 |
| Protein | Taxonomy | gamma-carboline (IC50) | methylene blue (IC50) |
|---|---|---|---|
| Chain E, Fibrin beta chain | Homo sapiens (human) | 9.253 | |
| integrase, partial | Human immunodeficiency virus 1 | 1.958 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 1.958 | |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | 15.5 | |
| neutrophil cytosol factor 1 | Homo sapiens (human) | 0.39 | |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | 17 | |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | 17 | |
| Glutathione reductase | Plasmodium falciparum 3D7 | 6.4 | |
| Amyloid-beta precursor protein | Homo sapiens (human) | 0.5 | |
| Microtubule-associated protein tau | Homo sapiens (human) | 2.2333 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.5 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.07 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.5 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aksinenko, AY; Aliev, G; Bachurin, SO; Boltneva, NP; Dubova, LG; Fisenko, VP; Kovaleva, NV; Lushchekina, SV; Makhaeva, GF; Richardson, RJ; Rudakova, EV; Shevtsova, EF; Sokolov, VB; Vinogradova, DV | 1 |
1 other study(ies) available for gamma-carboline and methylene blue
| Article | Year |
|---|---|
Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases.
Topics: Acetylcholinesterase; Animals; Antioxidants; Binding Sites; Butyrylcholinesterase; Carbolines; Carboxylesterase; Cholinesterase Inhibitors; Erythrocytes; Horses; Humans; Kinetics; Methylene Blue; Molecular Docking Simulation; Neurodegenerative Diseases; Swine | 2019 |